Dear Colleagues,

We are pleased to announce that, with the full endorsement of the AASLD, we have relaunched as SECURE-Liver (www.secureliver.org). Together with our collaborators at the EASL COVID-Hep.net, we aim to assess outcomes of COVID-19 in patients with chronic liver disease and prior liver transplant including updated questions on the role of living conditions and employment, alcohol use, thromboembolic complications, novel COVID-19 therapies, emerging SARS-CoV-2 variants and post-vaccination infections.

If you have any questions, please reach out to secure.liver@unc.edu

In addition to the reporting cases of COVID-19 to SECURE-Liver, we also encourage reporting to your local public health agency where applicable.

Sincerely,

Andrew M. Moon, MD, MPH (Assistant Professor of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill)

A. Sidney Barritt IV, MD, MSCR (Professor of Medicine, Division of Gastroenterology and Hepatology, Director of Hepatology, University of North Carolina at Chapel Hill)